Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDArcus Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$1.48 | -$0.93 | -$1.21 |
| Q2 2025 | 1 | -$1.83 | -$0.85 | -$1.24 |
| Q3 2025 | 1 | -$1.87 | -$0.87 | -$1.26 |
| Q4 2025 | 1 | -$1.94 | -$0.90 | -$1.31 |
| Q1 2026 | 1 | -$1.72 | -$0.80 | -$1.16 |
| Q2 2026 | 1 | -$1.62 | -$0.76 | -$1.10 |
| Q3 2026 | 1 | -$1.70 | -$0.79 | -$1.15 |
| Q4 2026 | 1 | -$1.67 | -$0.78 | -$1.13 |
| Q1 2027 | 1 | -$2.00 | -$0.93 | -$1.35 |
| Q2 2027 | 1 | -$1.84 | -$0.86 | -$1.25 |
| Q3 2027 | 1 | -$1.67 | -$0.78 | -$1.13 |
| Q4 2027 | 1 | -$1.55 | -$0.72 | -$1.05 |
| Q1 2028 | 1 | -$1.18 | -$0.55 | -$0.80 |
| Q2 2028 | 1 | -$0.88 | -$0.41 | -$0.59 |
| Q3 2028 | 1 | -$0.29 | -$0.14 | -$0.20 |
| Q4 2028 | 1 | $0.09 | $0.19 | $0.13 |
| Q1 2029 | 1 | $0.71 | $1.53 | $1.03 |
| Q2 2029 | 1 | $0.91 | $1.94 | $1.31 |
| Q3 2029 | 0 | $0.00 | $0.00 | $0.00 |
Arcus Biosciences, Inc. Earnings Date And Information
Arcus Biosciences, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-1 earnings per share for the quarter, topping analysts' consensus estimates of $-1.07 by $0.07. The company had revenue of 48.00 M for the quarter and had revenue of 117.00 M for the year. Arcus Biosciences, Inc. has generated $-4 earnings per share over the last year ($-4.15 diluted earnings per share) and currently has a price-to-earnings ratio of -5.12. Arcus Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Arcus Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$1.07 | -$1.01 | 0.06 | $38.95 M | $48.00 M |
| 08/08/2024 | Q2 2024 | -$1.02 | -$1.02 | 0 | $26.24 M | $39.00 M |
| 05/08/2024 | Q1 2024 | -$0.97 | -$0.05 | 0.92 | $145.00 M | |
| 02/21/2024 | Q4 2023 | -$1.09 | -$1.08 | 0.01 | $31.00 M | |
| 11/07/2023 | Q3 2023 | -$1.12 | -$0.95 | 0.17 | $27.28 M | $32.00 M |
| 08/07/2023 | Q2 2023 | -$1.00 | -$1.02 | -0.02 | $31.81 M | $29.00 M |
| 05/09/2023 | Q1 2023 | -$1.06 | -$1.10 | -0.04 | $25.00 M | |
| 02/28/2023 | Q4 2022 | -$0.99 | -$0.92 | 0.07 | $345,000 | |
| 11/02/2022 | Q3 2022 | -$1.05 | -$0.84 | 0.21 | $22.16 M | $33.58 M |
| 08/03/2022 | Q2 2022 | -$0.93 | -$0.90 | 0.03 | $21.57 M | $26.76 M |
| 05/09/2022 | Q1 2022 | $0.83 | -$0.96 | -1.79 | $18.01 M | |
| 02/23/2022 | Q4 2021 | -$0.74 | $3.97 | 4.71 | $354.50 M | |
| 11/08/2021 | Q3 2021 | -$1.13 | -$1.11 | 0.02 | $9.38 M | $9.46 M |
| 08/05/2021 | Q2 2021 | -$0.77 | -$1.09 | -0.32 | $13.06 M | $9.46 M |
| 05/05/2021 | Q1 2021 | -$0.71 | -$1.08 | -0.37 | $9.46 M | |
| 02/24/2021 | Q4 2020 | -$0.82 | $9.49 M | |||
| 11/05/2020 | Q3 2020 | $0.05 | $0.03 | -0.02 | $61.54 M | $64.53 M |
| 08/06/2020 | Q2 2020 | -$0.54 | -$0.93 | -0.39 | $1.61 M | $1.75 M |
| 05/05/2020 | Q1 2020 | -$0.56 | -$0.63 | -0.07 | $1.75 M | |
| 03/05/2020 | Q4 2019 | -$0.49 | -$0.38 | 0.11 | $9.75 M |
Arcus Biosciences, Inc. Earnings: FAQ's
When is Arcus Biosciences, Inc.'s earnings date?
Arcus Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
Did Arcus Biosciences, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Arcus Biosciences, Inc. (:RCUS) reported $-1 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.07 by $0.07.
How can I listen to Arcus Biosciences, Inc.'s earnings conference
call?
The conference call for Arcus Biosciences, Inc.'s latest earnings report can be listened to online.
How can I read Arcus Biosciences, Inc.'s conference call transcript?
The conference call transcript for Arcus Biosciences, Inc.'s latest earnings report can be read online.
How much revenue does Arcus Biosciences, Inc. generate each year?
Arcus Biosciences, Inc. (:RCUS) has a recorded annual revenue of $117.00 M.
How much profit does Arcus Biosciences, Inc. generate each year?
Arcus Biosciences, Inc. (:RCUS) has a recorded net income of $117.00 M. Arcus Biosciences, Inc. has generated $-4.15 earnings per share over the last four quarters.
What is Arcus Biosciences, Inc.'s price-to-earnings ratio?
Arcus Biosciences, Inc. (:RCUS) has a price-to-earnings ratio of -5.12 and price/earnings-to-growth ratio is 2.65.